Literature DB >> 17292807

Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death.

Yun Jeong Kim1, Hyun Hee Ko, Eun Sook Han, Chung Soo Lee.   

Abstract

Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the effect of antiepileptic lamotrigine against the cytotoxicity of mitochondrial respiratory complex I inhibitors rotenone and 1-methyl-4-phenylpyridinium (MPP+) in relation to the mitochondria-mediated cell death process and oxidative stress. Both rotenone and MPP+ induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in differentiated PC12 cells. Lamotrigine significantly attenuated the rotenone- or MPP+-induced mitochondrial damage leading to caspase-3 activation, increased oxidative stress and cell death. The preventive effect of lamotrigine against the toxicity of rotenone was greater than its effect on that of MPP+. The results show that lamotrigine seems to reduce the cytotoxicity of rotenone and MPP+ by suppressing the mitochondrial permeability transition formation, leading to cytochrome c release and subsequent activation of caspase-3. The preventive effect may be ascribed to its inhibitory action on the formation of reactive oxygen species and depletion of GSH. Lamotrigine seems to exert a protective effect against the neuronal cell injury due to the mitochondrial respiratory complex I inhibition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292807     DOI: 10.1016/j.brainresbull.2006.12.006

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism.

Authors:  Tereza Cikánková; Zdeněk Fišar; Jana Hroudová
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-19       Impact factor: 3.000

2.  DJ-1 knock-down impairs astrocyte mitochondrial function.

Authors:  N J Larsen; G Ambrosi; S J Mullett; S B Berman; D A Hinkle
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

Review 3.  A mitochondrial basis for Huntington's disease: therapeutic prospects.

Authors:  J Chakraborty; U Rajamma; K P Mohanakumar
Journal:  Mol Cell Biochem       Date:  2013-12-29       Impact factor: 3.396

Review 4.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

5.  Impact of Oxidative Stress and Newer Antiepileptic Drugs on the Albumin and Cortisol Value in Severe Motor and Intellectual Disabilities With Epilepsy.

Authors:  Masahito Morimoto; Toshiaki Hashimoto; Taisuke Kitaoka; Shojiro Kyotani
Journal:  J Clin Med Res       Date:  2017-12-30

6.  Molecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage.

Authors:  Dongming Guo; Xinlei Huang; Tianqing Xiong; Xingyi Wang; Jingwen Zhang; Yingge Wang; Jingyan Liang
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

7.  Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System.

Authors:  Rehab Abdelmonem; Marian Sobhy Azer; Amna Makky; Abdelazim Zaghloul; Mohamed El-Nabarawi; Aly Nada
Journal:  Drug Des Devel Ther       Date:  2020-10-19       Impact factor: 4.162

Review 8.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.